Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 275 entries
View as:

Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT06743464 Org: User:
Start: 12/01/24 End: 12/31/25 Due: 12/31/26

To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis

Phase: N/A Priority: Normal
NCT ID: NCT02468089 Org: User:
Start: 05/01/15 End: 08/31/17 Due: 08/31/18

The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT02484963 Org: User:
Start: 05/15/15 End: 01/15/17 Due: 01/15/18

High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics

Phase: N/A Priority: Normal
NCT ID: NCT03145168 Org: User:
Start: 09/19/18 End: 03/18/21 Due: 03/18/22

Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury

Phase: N/A Priority: Normal
NCT ID: NCT06809088 Org: User:
Start: 01/31/25 End: 01/31/26 Due: 01/31/27

To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.

Phase: N/A Priority: Normal
NCT ID: NCT03827681 Org: User:
Start: 02/06/19 End: 06/30/20 Due: 06/30/21

Impact of Weight Loss in Cirrhosis With Obesity and MAFLD

Phase: N/A Priority: Normal
NCT ID: NCT05104541 Org: User:
Start: 11/10/21 End: 11/09/23 Due: 11/09/24

Effect Of Delta Sodium on the Postoperative Outcomes in Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT04112004 Org: User:
Start: 01/01/11 End: 12/31/17 Due: 12/31/18

Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy

Phase: N/A Priority: Normal
NCT ID: NCT05229289 Org: User:
Start: 01/31/22 End: 12/31/22 Due: 12/31/23

Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After Optimization

Phase: N/A Priority: Normal
NCT ID: NCT04571957 Org: User:
Start: 12/01/18 End: 06/30/19 Due: 06/30/20

Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.

Phase: N/A Priority: Normal
NCT ID: NCT06175507 Org: User:
Start: 12/25/23 End: 03/31/25 Due: 03/31/26

Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children

Phase: N/A Priority: Normal
NCT ID: NCT05073588 Org: User:
Start: 08/16/21 End: 03/30/23 Due: 03/30/24

A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids

Phase: N/A Priority: Normal
NCT ID: NCT06031740 Org: User:
Start: 09/07/23 End: 08/31/24 Due: 08/31/25

Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.

Phase: N/A Priority: Normal
NCT ID: NCT05690750 Org: User:
Start: 01/19/23 End: 04/30/23 Due: 04/30/24

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

Phase: N/A Priority: Normal
NCT ID: NCT02458079 Org: User:
Start: 12/01/14 End: 07/27/16 Due: 07/27/17

Randomized Controlled Trial to Study the Outcome of Intravenous Phosphate Supplementation in Live Donors Undergoing Hepatectomy for Living Donor Liver Transplantation (LDLT)

Phase: N/A Priority: Normal
NCT ID: NCT04026438 Org: User:
Start: 01/21/19 End: 02/24/21 Due: 02/24/22

Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT03162198 Org: User:
Start: 05/15/17 End: 10/31/18 Due: 10/31/19

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02739581 Org: User:
Start: - End: 04/30/19 Due: 04/30/20

Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT06818279 Org: User:
Start: 01/31/25 End: 01/31/26 Due: 01/31/27

Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices

Phase: N/A Priority: Normal
NCT ID: NCT05057572 Org: User:
Start: 10/01/21 End: 12/31/23 Due: 12/31/24

Organ Dysfunction Associated With Intra Abdominal Pressures in Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04463745 Org: User:
Start: 07/15/20 End: 06/30/21 Due: 06/30/22

An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT04352491 Org: User:
Start: 04/24/20 End: 05/31/20 Due: 05/31/21

TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

Phase: N/A Priority: Normal
NCT ID: NCT05195450 Org: User:
Start: 02/23/22 End: 12/31/27 Due: 12/31/28

Effect of Saturated Fat (Desi Ghee) on Gut-Liver Axis in Alcoholic Hepatitis

Phase: N/A Priority: Normal
NCT ID: NCT04084522 Org: User:
Start: 10/01/19 End: 01/31/22 Due: 01/31/23

Preoperative Sepsis Timeline, Profile and Its Association With Recipient Outcome Following Live Donor Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05109156 Org: User:
Start: 11/05/21 End: 04/30/22 Due: 04/30/23